Your browser doesn't support javascript.
loading
Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging.
Tawakol, Ahmed; Singh, Parmanand; Rudd, James H F; Soffer, Joseph; Cai, Gengqian; Vucic, Esad; Brannan, Sarah P; Tarka, Elizabeth A; Shaddinger, Bonnie C; Sarov-Blat, Lea; Matthews, Paul; Subramanian, Sharath; Farkouh, Michael; Fayad, Zahi A.
Afiliação
  • Tawakol A; Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: atawakol@partners.org.
  • Singh P; Cardiac MR-PET-CT Program, Division of Cardiac Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Rudd JH; Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Soffer J; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, Pennsylvania.
  • Cai G; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, Pennsylvania.
  • Vucic E; Cardiac MR-PET-CT Program, Division of Cardiac Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Brannan SP; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, Pennsylvania.
  • Tarka EA; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, Pennsylvania.
  • Shaddinger BC; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, Pennsylvania.
  • Sarov-Blat L; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, Pennsylvania.
  • Matthews P; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, Pennsylvania; Division of Brain Sciences, Imperial College London, London, United Kingdom.
  • Subramanian S; Cardiac MR-PET-CT Program, Division of Cardiac Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Farkouh M; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Peter Munk Cardic Centre and the Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada.
  • Fayad ZA; Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
J Am Coll Cardiol ; 63(1): 86-8, 2014.
Article em En | MEDLINE | ID: mdl-23973698
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arterite / Fluordesoxiglucose F18 / 1-Alquil-2-acetilglicerofosfocolina Esterase / Tomografia por Emissão de Pósitrons / Inibidores de Fosfolipase A2 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arterite / Fluordesoxiglucose F18 / 1-Alquil-2-acetilglicerofosfocolina Esterase / Tomografia por Emissão de Pósitrons / Inibidores de Fosfolipase A2 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2014 Tipo de documento: Article